Thailand Hub of Talents in Cancer Immunotherapy (TTCI Thailand) https://validator.w3.org/feed/docs/rss2.html International Collaborator Research Topics Research News A multi-center clinical research project to study the Safety and Efficacy of CD19 CAR T-cells in ALL (Acute Lymphoblastic Leukemia) by Academic Hubs A Phase 1b clinical trial to evaluate the safety and efficacy of BCMA-targeted CAR T-cell therapy in Thai patients with relapsed or refractory multiple myeloma. Assessment of the Immunomodulatory Potential of Spirulina Blue Protein Capsule on Immunomodulation in Healthy Volunteers Chulalongkorn University Team Our Team University of Phayao Princess Srisavangavadhana Faculty of Medicine Suranaree University of Technology Indiana University School of Medicine Functional Characterization of Lactobacillus gasseri Isolates Using Jurkat T Cells Development of CD147-Specific CAR-T Cells for T-cell Acute Lymphoblastic Leukemia (T-ALL) Immunotherapy Identification of Shared HLA-A*11:01–Presented Tumor-Associated Antigens Across Multiple Cancer Types Using Organoid Models. Thermal Stability Profiling of HLA-A*11:01–Peptide Complexes Comparative real-world effectiveness and tolerability of later-line therapies in chemotherapy-refractory metastatic colorectal cancer A Pragmatic, Open-label Trial of SB4456 to Evaluate Safety and Clinical Responses in Stage 4 Recurrent/Metastatic Non-small Cell Lung Cancer Patients in Thailand Impact of clonal hematopoiesis on outcomes in metastatic pancreatic ductal adenocarcinoma: Analysis from the PASS-01 Trial Antifungal drug resistance screening of Aspergillus spp. at King Chulalongkorn Memorial Hospital; Screening novel small molecule inhibitors for antifungal activity against medically important fungi Investigation of Anticancer Mechanisms and Immunomodulatory Effects of Spirulina Extract in Lung Cancer Cells Development of Immunotherapy for Autoimmune Disease Treatment Discovery and characterization of human monoclonal antibodies targeting cell adhesion molecule 1 (CADM1) and evaluation of recombinant antibody formats for potential therapeutic and diagnostic applications. Discovery, engineering and production of recombinant antibodies for potential diagnostics and therapeutic applications AICEDA Liver: Enhancing Rural Health Care with Remote Deep Learning-Assisted Liver Cancer Screening Quality of End-of-Life Cancer Care in Thailand: A Population-Based Study of Palliative Care Quality Indicators Using National Health Security Office (NHSO) e-Claim Data Deep Learning-Assisted Immunohistochemistry Scoring in Cancer: Ki-67 in Breast Cancer and Claudin 18.2 / PD-L1 in Gastric and Gastroesophageal Junction Cancer Cancer Clinical Trials: Industry-Sponsored and Investigator-Initiated Phase II–III Studies in Solid Tumours A Multi-Modal Analysis of 3D-Printed WE43 Magnesium Alloy for Mandibular Reconstruction in Oral Squamous Cell Carcinoma Cancer Clinical Trials: Industry-Sponsored and Investigator-Initiated Phase II–III Studies in Solid Tumours TTCI Delegation at The 30th Annual Meeting of the Japanese Association of Cancer Immunology (JACI 2026) Major Milestone for TTCI: Honored with the Prestigious NRCT AWARD 2026 (Award Ceremony 26 October 2026) TTCI Congratulates Assoc. Prof. Dr. Jakkarawadee Julamanee on Receiving Prestigious National Research and Innovation Awards TTCI Congratulates Asst. Prof. Dr. Jutharp Phetcharaburanin on Receiving Prestigious Khon Kaen University Honorary Awards 2026 TTCI Congratulates Prof. Dr. Chanitra Thuwajit on Receiving Mahidol University’s “Global Talent” Award (Advanced Level) 2025 TTCI Congratulates Lect. Dr. Suyanee Thongchot on Receiving DMSc First Prize Award and Outstanding Alumni Award 2026 TTCI Congratulates Prof. Nattiya Hirankarn on Receiving the “National Outstanding Lecturer Award” and Chulalongkorn University’s “Role Model Lecturer Award” in Health Sciences TTCI Representative Delivers Award-Winning Oral Presentation at JACI 2026 in Japan Special Seminar: A Preinvasive Regulatory T Cell Axis for Lung Cancer Interception by Dr. Teerapon Sahwangarrom Seminar: Preclinical Evaluation System Using BRJ (BALB/c Rag-2/Jak3 Double-Knockout) Mice by Prof. Seiji Okada Antigen Discovery for Development of Personalised Cancer Immunotherapy by Assoc. Prof. Michal Bassani-Sternberg International Summit on Cellular Immunotherapy 2026 TTCI Webinar Series “Immunometabolism : From Metabolomics to Respiration” Vaccine and Therapeutic RNA Research Forum 2025 NRCT Hosts Seminar on “Thai Cancer Immunotherapy: Collaboration, Regulation, and the Future of Treatment” at MHESI Fair 2025 Operational Readiness, Safety, and Quality Management for ATMP Clinical Trials in Thailand Personalized Cancer Vaccines – A New Frontier in Thailand’s Fight Against Cancer On-demand GLUT3 expression augments CAR-T cell metabolic fitness and antitumor efficacy in glioblastoma models Cell Therapy for Solid Cancers: Promise or Overpromise? Thailand Hub of Talents in Cancer Immunotherapy (TTCI Thailand)